ADC Program

About Lantern Pharma

Lantern Pharma is an emerging, oncology-focused biopharmaceutical company at the intersection of artificial intelligence, genomics, and machine learning. Its core asset is the RADR® platform, which leverages approximately 200 billion oncology-focused data points and over 200 ML algorithms to de-risk and accelerate drug development. The company's mission is to deliver targeted therapies to the right cancer patients, with a current portfolio spanning three lead drug candidates and an ADC program across 12 cancer indications.

Therapeutic Areas